tiprankstipranks
Trending News
More News >
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
US Market

BioCryst (BCRX) Income Statement

Compare
2,606 Followers

BioCryst Income Statement

Last quarter (Q3 2025), BioCryst's total revenue was $159.40M, an increase of 36.14% from the same quarter last year. In Q3, BioCryst's net income was $12.90M. See BioCryst’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 450.71M$ 331.41M$ 270.83M$ 157.17M$ 17.81M
Gross Profit
$ 438.23M$ 326.75M$ 264.23M$ 149.91M$ 16.14M
Operating Expenses
$ 440.77M$ 430.46M$ 412.67M$ 327.63M$ 190.89M
Depreciation and Amortization
$ 1.25M$ 1.66M$ 1.44M$ 777.00K$ 748.00K
EBITDA
$ 12.81M$ -116.33M$ -143.85M$ -121.74M$ -167.56M
Operating Income
$ -2.54M$ -103.71M$ -148.44M$ -177.72M$ -174.76M
Other Income/Expenses
$ -84.41M$ -122.52M$ -95.95M$ -4.09M$ -8.06M
Pretax Income
$ -86.95M$ -226.23M$ -244.38M$ -181.81M$ -182.81M
Net Income
$ -88.88M$ -226.54M$ -247.12M$ -184.06M$ -182.81M
Per Share Metrics
Basic EPS
$ -0.43$ -1.18$ -1.33$ -1.03$ -1.09
Diluted EPS
$ -0.43$ -1.18$ -1.33$ -1.03$ -1.09
Weighted Average Shares Outstanding
206.70M 192.20M 185.91M 179.12M 167.27M
Weighted Average Shares Outstanding (Diluted)
206.70M 192.20M 185.91M 179.12M 167.27M
Currency in USD

BioCryst Earnings and Revenue History